TMEM248 inhibitors are a class of chemical compounds designed to selectively bind to and inhibit the function of the transmembrane protein TMEM248. TMEM248, short for Transmembrane Protein 248, is a protein that, as its name suggests, spans the membrane of cells and is involved in various cellular processes. The inhibitors targeting this protein are typically small molecules that can cross the cell membrane to interact with TMEM248. The exact mechanism by which these inhibitors affect the protein's function can vary, but generally, they work by binding to the protein with high affinity, which results in the modulation of its activity. This modulation can affect the protein's natural behavior, such as its interaction with other cellular components or its role in the maintenance of cellular homeostasis.
The development and study of TMEM248 inhibitors involve extensive research into the structure and function of the TMEM248 protein itself. Understanding the protein's role at the molecular level is crucial for the rational design of effective inhibitors. Researchers use a variety of techniques such as X-ray crystallography, nuclear magnetic resonance (NMR) spectroscopy, and computational modeling to determine the three-dimensional structure of the protein and identify potential binding sites for inhibitors. Once potential inhibitors are identified, they are synthesized and subjected to various biochemical assays to evaluate their binding efficiency and specificity for TMEM248. These studies are also complemented by biophysical experiments to analyze the interaction between the protein and the inhibitor, which includes assessing the binding kinetics and thermodynamics. The collective data from these investigations help in understanding how TMEM248 inhibitors interact with the protein at the atomic level and what structural features are crucial for their function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide is a compound that inhibits eukaryotic protein synthesis by interfering with the translocation step in protein synthesis, thus potentially reducing the abundance of TMEM248 if it was being actively synthesized. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin is an mTOR inhibitor that leads to the downregulation of protein synthesis and can indirectly affect the levels of TMEM248 by decreasing the overall rate of protein translation in the cell. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that impedes the PI3K/AKT/mTOR signaling pathway, which is involved in protein synthesis. Inhibition of this pathway could result in decreased synthesis of TMEM248. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil is a pyrimidine analog that disrupts nucleotide synthesis and can indirectly lead to reduced transcription and translation of proteins, possibly affecting TMEM248 levels. | ||||||
Wiskostatin | 253449-04-6 | sc-204399 sc-204399A sc-204399B sc-204399C | 1 mg 5 mg 25 mg 50 mg | $49.00 $124.00 $441.00 $828.00 | 4 | |
WZB117 is a GLUT1 inhibitor that restricts glucose uptake in cells, potentially impacting the glycosylation and proper folding of proteins like TMEM248 that may be glycoproteins. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is known to raise the pH of acidic organelles and can interfere with the glycosylation in the Golgi apparatus, which might influence the stability and function of glycoproteins such as TMEM248. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Brefeldin A disrupts the function of the Golgi apparatus, potentially affecting the post-translational modification and trafficking of proteins like TMEM248. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
MG132 is a proteasome inhibitor that can lead to the accumulation of misfolded proteins, potentially affecting the degradation pathway of TMEM248 if it were misfolded or tagged for degradation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Bortezomib is another proteasome inhibitor that can alter the protein homeostasis within the cell, potentially influencing the turnover of TMEM248. | ||||||
Pertussis Toxin (islet-activating protein) | 70323-44-3 | sc-200837 | 50 µg | $451.00 | 3 | |
Pertussis toxin irreversibly disables the Gi subunit of G-proteins, which could indirectly affect signaling pathways that might regulate the expression or function of TMEM248. | ||||||